EHMT2_HUMAN - dbPTM
EHMT2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID EHMT2_HUMAN
UniProt AC Q96KQ7
Protein Name Histone-lysine N-methyltransferase EHMT2
Gene Name EHMT2
Organism Homo sapiens (Human).
Sequence Length 1210
Subcellular Localization Nucleus . Chromosome . Associates with euchromatic regions. Does not associate with heterochromatin.
Protein Description Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also mediates monomethylation of 'Lys-56' of histone H3 (H3K56me1) in G1 phase, leading to promote interaction between histone H3 and PCNA and regulating DNA replication. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. May also methylate histone H1. In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53. Also methylates CDYL, WIZ, ACIN1, DNMT1, HDAC1, ERCC6, KLF12 and itself..
Protein Sequence MAAAAGAAAAAAAEGEAPAEMGALLLEKETRGATERVHGSLGDTPRSEETLPKATPDSLEPAGPSSPASVTVTVGDEGADTPVGATPLIGDESENLEGDGDLRGGRILLGHATKSFPSSPSKGGSCPSRAKMSMTGAGKSPPSVQSLAMRLLSMPGAQGAAAAGSEPPPATTSPEGQPKVHRARKTMSKPGNGQPPVPEKRPPEIQHFRMSDDVHSLGKVTSDLAKRRKLNSGGGLSEELGSARRSGEVTLTKGDPGSLEEWETVVGDDFSLYYDSYSVDERVDSDSKSEVEALTEQLSEEEEEEEEEEEEEEEEEEEEEEEEDEESGNQSDRSGSSGRRKAKKKWRKDSPWVKPSRKRRKREPPRAKEPRGVNGVGSSGPSEYMEVPLGSLELPSEGTLSPNHAGVSNDTSSLETERGFEELPLCSCRMEAPKIDRISERAGHKCMATESVDGELSGCNAAILKRETMRPSSRVALMVLCETHRARMVKHHCCPGCGYFCTAGTFLECHPDFRVAHRFHKACVSQLNGMVFCPHCGEDASEAQEVTIPRGDGVTPPAGTAAPAPPPLSQDVPGRADTSQPSARMRGHGEPRRPPCDPLADTIDSSGPSLTLPNGGCLSAVGLPLGPGREALEKALVIQESERRKKLRFHPRQLYLSVKQGELQKVILMLLDNLDPNFQSDQQSKRTPLHAAAQKGSVEICHVLLQAGANINAVDKQQRTPLMEAVVNNHLEVARYMVQRGGCVYSKEEDGSTCLHHAAKIGNLEMVSLLLSTGQVDVNAQDSGGWTPIIWAAEHKHIEVIRMLLTRGADVTLTDNEENICLHWASFTGSAAIAEVLLNARCDLHAVNYHGDTPLHIAARESYHDCVLLFLSRGANPELRNKEGDTAWDLTPERSDVWFALQLNRKLRLGVGNRAIRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLARLDPHPELLPELGSLPPVNT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAAAAGAAA
------CHHHHHHHH
19.6722814378
40PhosphorylationATERVHGSLGDTPRS
CCHHCCCCCCCCCCC
17.8225159151
44PhosphorylationVHGSLGDTPRSEETL
CCCCCCCCCCCCCCC
20.8525159151
47PhosphorylationSLGDTPRSEETLPKA
CCCCCCCCCCCCCCC
40.7725159151
50PhosphorylationDTPRSEETLPKATPD
CCCCCCCCCCCCCCC
44.2923403867
55PhosphorylationEETLPKATPDSLEPA
CCCCCCCCCCCCCCC
33.4820068231
58PhosphorylationLPKATPDSLEPAGPS
CCCCCCCCCCCCCCC
35.5230278072
65PhosphorylationSLEPAGPSSPASVTV
CCCCCCCCCCCEEEE
48.3030576142
66PhosphorylationLEPAGPSSPASVTVT
CCCCCCCCCCEEEEE
27.8430576142
69PhosphorylationAGPSSPASVTVTVGD
CCCCCCCEEEEEECC
23.0030278072
71PhosphorylationPSSPASVTVTVGDEG
CCCCCEEEEEECCCC
14.1530576142
73PhosphorylationSPASVTVTVGDEGAD
CCCEEEEEECCCCCC
14.9220068231
81PhosphorylationVGDEGADTPVGATPL
ECCCCCCCCCCCCCC
21.2429496963
86PhosphorylationADTPVGATPLIGDES
CCCCCCCCCCCCCCC
16.8220068231
93PhosphorylationTPLIGDESENLEGDG
CCCCCCCCCCCCCCC
36.2028348404
113PhosphorylationRILLGHATKSFPSSP
EEEEEEEECCCCCCC
22.8827174698
114TrimethylationILLGHATKSFPSSPS
EEEEEEECCCCCCCC
51.38-
114MethylationILLGHATKSFPSSPS
EEEEEEECCCCCCCC
51.38-
115PhosphorylationLLGHATKSFPSSPSK
EEEEEECCCCCCCCC
37.7323403867
118PhosphorylationHATKSFPSSPSKGGS
EEECCCCCCCCCCCC
53.5230266825
119PhosphorylationATKSFPSSPSKGGSC
EECCCCCCCCCCCCC
33.1730266825
121PhosphorylationKSFPSSPSKGGSCPS
CCCCCCCCCCCCCCC
45.9730266825
122MethylationSFPSSPSKGGSCPSR
CCCCCCCCCCCCCCC
71.34-
125PhosphorylationSSPSKGGSCPSRAKM
CCCCCCCCCCCCCCC
31.3626552605
128PhosphorylationSKGGSCPSRAKMSMT
CCCCCCCCCCCCCCC
49.5523312004
131MethylationGSCPSRAKMSMTGAG
CCCCCCCCCCCCCCC
30.33-
133PhosphorylationCPSRAKMSMTGAGKS
CCCCCCCCCCCCCCC
16.7023927012
135PhosphorylationSRAKMSMTGAGKSPP
CCCCCCCCCCCCCCH
19.3023927012
139AcetylationMSMTGAGKSPPSVQS
CCCCCCCCCCHHHHH
60.2925953088
140PhosphorylationSMTGAGKSPPSVQSL
CCCCCCCCCHHHHHH
40.9229255136
140 (in isoform 2)Phosphorylation-40.9218220336
143PhosphorylationGAGKSPPSVQSLAMR
CCCCCCHHHHHHHHH
35.8529255136
146PhosphorylationKSPPSVQSLAMRLLS
CCCHHHHHHHHHHHC
18.8823927012
149SulfoxidationPSVQSLAMRLLSMPG
HHHHHHHHHHHCCCC
3.6321406390
153PhosphorylationSLAMRLLSMPGAQGA
HHHHHHHCCCCCCCH
27.7622199227
165PhosphorylationQGAAAAGSEPPPATT
CCHHHCCCCCCCCCC
42.0530266825
171PhosphorylationGSEPPPATTSPEGQP
CCCCCCCCCCCCCCC
33.3130266825
172PhosphorylationSEPPPATTSPEGQPK
CCCCCCCCCCCCCCC
44.3730266825
173PhosphorylationEPPPATTSPEGQPKV
CCCCCCCCCCCCCCC
19.3230266825
184MethylationQPKVHRARKTMSKPG
CCCCCCCCCCCCCCC
34.63-
185"N6,N6,N6-trimethyllysine"PKVHRARKTMSKPGN
CCCCCCCCCCCCCCC
47.82-
185MethylationPKVHRARKTMSKPGN
CCCCCCCCCCCCCCC
47.8218438403
189MethylationRARKTMSKPGNGQPP
CCCCCCCCCCCCCCC
46.2324129315
211PhosphorylationEIQHFRMSDDVHSLG
CCCEEECCCCHHHHC
26.8020068231
216PhosphorylationRMSDDVHSLGKVTSD
ECCCCHHHHCHHHHH
38.3720068231
219AcetylationDDVHSLGKVTSDLAK
CCHHHHCHHHHHHHH
47.8625953088
219SumoylationDDVHSLGKVTSDLAK
CCHHHHCHHHHHHHH
47.8628112733
221PhosphorylationVHSLGKVTSDLAKRR
HHHHCHHHHHHHHHC
21.7329083192
222PhosphorylationHSLGKVTSDLAKRRK
HHHCHHHHHHHHHCC
33.3529083192
229SumoylationSDLAKRRKLNSGGGL
HHHHHHCCCCCCCCC
56.9328112733
229UbiquitinationSDLAKRRKLNSGGGL
HHHHHHCCCCCCCCC
56.93-
232PhosphorylationAKRRKLNSGGGLSEE
HHHCCCCCCCCCCHH
49.6129255136
232 (in isoform 2)Phosphorylation-49.6118220336
237PhosphorylationLNSGGGLSEELGSAR
CCCCCCCCHHHHCCC
32.0925159151
242PhosphorylationGLSEELGSARRSGEV
CCCHHHHCCCCCCEE
31.0925159151
246PhosphorylationELGSARRSGEVTLTK
HHHCCCCCCEEEEEC
33.4830266825
250PhosphorylationARRSGEVTLTKGDPG
CCCCCEEEEECCCCC
25.1429449344
252PhosphorylationRSGEVTLTKGDPGSL
CCCEEEEECCCCCCH
24.50-
258PhosphorylationLTKGDPGSLEEWETV
EECCCCCCHHHEEEE
37.6922468782
327PhosphorylationEEEEDEESGNQSDRS
HHHHHHHCCCCCCCC
40.7825137130
331PhosphorylationDEESGNQSDRSGSSG
HHHCCCCCCCCCCHH
38.7025137130
336PhosphorylationNQSDRSGSSGRRKAK
CCCCCCCCHHHHHHH
30.7619651622
337PhosphorylationQSDRSGSSGRRKAKK
CCCCCCCHHHHHHHH
39.5825137130
350PhosphorylationKKKWRKDSPWVKPSR
HHHHHCCCCCCCCCH
24.5623927012
356PhosphorylationDSPWVKPSRKRRKRE
CCCCCCCCHHCCCCC
44.7219691289
378 (in isoform 2)Phosphorylation-29.7025159151
379PhosphorylationGVNGVGSSGPSEYME
CCCCCCCCCCHHCEE
49.1219691289
379 (in isoform 2)Phosphorylation-49.1225849741
391PhosphorylationYMEVPLGSLELPSEG
CEEECCCCCCCCCCC
26.7626074081
396PhosphorylationLGSLELPSEGTLSPN
CCCCCCCCCCCCCCC
62.3726074081
399PhosphorylationLELPSEGTLSPNHAG
CCCCCCCCCCCCCCC
21.7326074081
401PhosphorylationLPSEGTLSPNHAGVS
CCCCCCCCCCCCCCC
24.4028387310
408PhosphorylationSPNHAGVSNDTSSLE
CCCCCCCCCCCCCCC
28.2428450419
411PhosphorylationHAGVSNDTSSLETER
CCCCCCCCCCCCCCC
25.1919691289
412PhosphorylationAGVSNDTSSLETERG
CCCCCCCCCCCCCCC
35.4728176443
413PhosphorylationGVSNDTSSLETERGF
CCCCCCCCCCCCCCC
32.1128176443
416PhosphorylationNDTSSLETERGFEEL
CCCCCCCCCCCCCCC
35.9519691289
445MethylationISERAGHKCMATESV
HHHHHCCCEEEECCC
25.45-
468PhosphorylationAAILKRETMRPSSRV
EEHHHHCCCCCCHHH
23.63-
555PhosphorylationIPRGDGVTPPAGTAA
ECCCCCCCCCCCCCC
29.1430266825
560PhosphorylationGVTPPAGTAAPAPPP
CCCCCCCCCCCCCCC
23.0430266825
569PhosphorylationAPAPPPLSQDVPGRA
CCCCCCCCCCCCCCC
30.0617525332
634SumoylationPGREALEKALVIQES
CCHHHHHHHHHHCHH
48.1228112733
634UbiquitinationPGREALEKALVIQES
CCHHHHHHHHHHCHH
48.12-
641PhosphorylationKALVIQESERRKKLR
HHHHHCHHHHHHHCC
21.74-
659UbiquitinationRQLYLSVKQGELQKV
HHHEEEECCHHHHHH
49.57-
685UbiquitinationFQSDQQSKRTPLHAA
CCCCHHHCCCHHHHH
56.82-
747AcetylationRGGCVYSKEEDGSTC
CCCCEEECCCCCCCC
47.6526051181
747UbiquitinationRGGCVYSKEEDGSTC
CCCCEEECCCCCCCC
47.65-
848 (in isoform 2)Ubiquitination-24.7021890473
882UbiquitinationANPELRNKEGDTAWD
CCHHHCCCCCCCCCC
57.55-
882 (in isoform 1)Ubiquitination-57.5521890473
920UbiquitinationNRAIRTEKIICRDVA
CHHHHCEEEEEHHHH
36.44-
998UbiquitinationSIRCWYDKDGRLLQE
EEEEEECCCCCCHHH
46.52-
1013UbiquitinationFNKIEPPLIFECNQA
HHCCCCCEEEEECCC
11.6521890473
1013 (in isoform 2)Ubiquitination-11.6521890473
1047UbiquitinationLQLYRTAKMGWGVRA
HHHHHHHCCCCCEEE
37.0121890473
1047UbiquitinationLQLYRTAKMGWGVRA
HHHHHHHCCCCCEEE
37.01-
1047 (in isoform 1)Ubiquitination-37.0121890473
1084PhosphorylationADVREDDSYLFDLDN
CCCCCCCCEEEECCC
35.7427499020
1085PhosphorylationDVREDDSYLFDLDNK
CCCCCCCEEEECCCC
20.55-
1103PhosphorylationVYCIDARYYGNISRF
EEEEECEEECCHHHH
19.9020860994
1104PhosphorylationYCIDARYYGNISRFI
EEEECEEECCHHHHH
9.7220860994
1108PhosphorylationARYYGNISRFINHLC
CEEECCHHHHHHHHC
25.7420860994
1164UbiquitinationRFWDIKSKYFTCQCG
CCEEECCCEEECCCC
39.11-
1187PhosphorylationEAIALEQSRLARLDP
HHHHHHHHHHHHCCC
21.6429743597
1204PhosphorylationELLPELGSLPPVNT-
HHCHHHCCCCCCCC-
50.7823663014
1210PhosphorylationGSLPPVNT-------
CCCCCCCC-------
39.9721082442

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
211SPhosphorylationKinaseCSNK2A1P68400
GPS
569SPhosphorylationKinaseATMQ13315
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
185KMethylation

18438403

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of EHMT2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PRC2B_HUMANPRRC2Bphysical
16189514
LCOR_HUMANC10orf12physical
16189514
THAP7_HUMANTHAP7physical
16189514
KLF12_HUMANKLF12physical
16189514
LNX1_HUMANLNX1physical
16189514
CCD33_HUMANCCDC33physical
16189514
PRDM1_HUMANPRDM1physical
19124609
H14_HUMANHIST1H1Ephysical
19144645
UHRF1_HUMANUHRF1physical
19943104
UHRF1_HUMANUHRF1physical
19056828
CBX1_HUMANCBX1physical
19706462
RELB_HUMANRELBphysical
19690169
DNMT1_HUMANDNMT1physical
17085482
Z512B_HUMANZNF512Bphysical
20211142
MED12_HUMANMED12physical
18691967
EHMT1_MOUSEEhmt1physical
16702210
WIZ_MOUSEWizphysical
16702210
WIZ_HUMANWIZphysical
16702210
CTBP1_HUMANCTBP1physical
16702210
CTBP2_HUMANCTBP2physical
16702210
GFI1B_HUMANGFI1Bphysical
16688220
MED23_HUMANMED23physical
18691967
CDK8_HUMANCDK8physical
18691967
MED6_HUMANMED6physical
18691967
EVI1_HUMANMECOMphysical
18619962
GRIP1_HUMANGRIP1physical
16461774
GFI1_HUMANGFI1physical
16287849
ESCO2_HUMANESCO2physical
18501190
H31_HUMANHIST1H3Aphysical
16185068
EHMT2_HUMANEHMT2physical
17962312
CBX5_HUMANCBX5physical
17962312
CBX1_HUMANCBX1physical
17962312
CBX3_HUMANCBX3physical
17962312
PRDM5_HUMANPRDM5physical
17636019
KDM1B_HUMANKDM1Bphysical
20670891
SMC1A_HUMANSMC1Aphysical
20670891
ESCO1_HUMANESCO1physical
20331966
H31_HUMANHIST1H3Aphysical
20118233
P53_HUMANTP53physical
20118233
PO5F1_HUMANPOU5F1physical
21151833
H31T_HUMANHIST3H3physical
12700765
NR0B2_HUMANNR0B2physical
21566081
SMRCD_HUMANSMARCAD1physical
21549307
UHRF1_HUMANUHRF1physical
22064703
UHRF2_HUMANUHRF2physical
22064703
H32_HUMANHIST2H3Cphysical
22387026
DNM3A_HUMANDNMT3Aphysical
22086334
H32_HUMANHIST2H3Cphysical
21495674
H32_HUMANHIST2H3Cphysical
15269344
CUX1_HUMANCUX1physical
15269344
CASP_HUMANCUX1physical
15269344
MIER1_HUMANMIER1physical
21258344
HDAC2_HUMANHDAC2physical
21258344
WIZ_HUMANWIZphysical
21258344
EHMT1_HUMANEHMT1physical
21258344
CDYL_HUMANCDYLphysical
21258344
REST_HUMANRESTphysical
15200951
CBX5_HUMANCBX5physical
15200951
CBX1_HUMANCBX1physical
15200951
CBX3_HUMANCBX3physical
15200951
CTNA3_HUMANCTNNA3physical
23718855
PRDM1_HUMANPRDM1physical
14985713
H11_HUMANHIST1H1Aphysical
14985713
PML_HUMANPMLphysical
23768491
LCOR_HUMANC10orf12physical
25416956
CHCH2_HUMANCHCHD2physical
25416956
KLF3_HUMANKLF3physical
25416956
F161A_HUMANFAM161Aphysical
25416956
PNCB_HUMANNAPRTphysical
25416956
ZN785_HUMANZNF785physical
25416956
ZBT38_HUMANZBTB38physical
25416956
RD3_HUMANRD3physical
25416956
KAT2B_HUMANKAT2Bphysical
24492005
AB17A_HUMANABHD17Aphysical
21516116
H31_BOVINHIST1H3Cphysical
25420628
DNLI1_HUMANLIG1physical
28803780
DNLI1_MOUSELig1physical
28803780

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of EHMT2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-232, AND MASS SPECTROMETRY.
Methylation
ReferencePubMed
"Protein lysine methyltransferase G9a acts on non-histone targets.";
Rathert P., Dhayalan A., Murakami M., Zhang X., Tamas R.,Jurkowska R., Komatsu Y., Shinkai Y., Cheng X., Jeltsch A.;
Nat. Chem. Biol. 4:344-346(2008).
Cited for: FUNCTION, METHYLATION AT LYS-185, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-232, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140; SER-173; SER-232;SER-246 AND THR-1210, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140 AND SER-232, ANDMASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-246, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-246, AND MASSSPECTROMETRY.

TOP